Clinical trial · Observational
A Study of Circulating Immune Cell Activity Changes in Blood of Colorectal Cancer Patients
NCT02869269CI-TRIAL-00031419completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Previous studies have shown that colorectal cancer patients' prognosis and overall survival was related with immune cell expression in patients' tissue. However, the circulating immune cell activity changes in patients' blood has few studies. The purpose of this study is to analyze the variation of circulating immune cell activity in colorectal patients' blood which is classed as clinical staging.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Early stage | Device | — | UNRESOLVED |
| Late stage | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Early stage
- description
- patients who diagnosed as TNM stage 1 and 2
- interventionNames
- Device: Early stage
- label
- Late stage
- description
- patients who diagnosed as TNM stage 3 and 4
- interventionNames
- Device: Late stage
Primary outcomes (1)
- measure
- Circulating helper T cell activity
- timeFrame
- preoperative time
- description
- change of expression level of T cell (0\~100 %)
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * patient who was planned to undergo colorectal cancer surgery. Exclusion Criteria: * age \< 20 years old * history of hypersensitivity reaction in propofol or sevoflurane * history of previous cancer * patient with ongoing inflammation
References
Publications (0)
Data not yet available
No reference posted for this study.